Pulmonary manifestations in inflammatory bowel disease: a prospective study

  • Devendra DesaiEmail author
  • Samir Patil
  • Zarir Udwadia
  • Shailendra Maheshwari
  • Philip Abraham
  • Anand Joshi
Original Article



Although pulmonary abnormalities have been recognized in patients with inflammatory bowel diseases (IBD), their prevalence and clinical significance are not known.


To study the prevalence and clinical significance of pulmonary abnormalities in patients with IBD.


Ninety-five non-consecutive patients with IBD (12 Crohn’s disease, 83 ulcerative colitis; mean age 41.9 [SD 13] years; 47 women) were prospectively studied from January 2007 to March 2010. Pulmonary function tests (PFT) and high-resolution CT (HRCT) chest were performed in them. PFT were compared to those in 270 healthy (control) subjects matched for age, sex and smoking status.


Twenty-seven (28.5%) patients and 11 (4%) control subjects had abnormal PFT (p < 0.0001). Small airway obstruction was seen in 18 patients, restrictive defect in six and mixed defect in three. Twenty-one (22%) patients had abnormal HRCT findings – bronchiectasis and nodules (nine patients each, including one with nodules who later developed active tuberculosis after infliximab therapy), parenchymal bands (8), mediastinal lymphadenopathy (five, including two with tuberculosis on histology and culture), emphysema (5), brochiolitis (2), pleural effusion or thickening (2), pericardial effusion (2), patchy consolidation (1), ground-glass opacities (1) and lung metastasis (1). Three patients had symptoms (one asthma, two cough).


PFT and HRCT chest showed abnormality in about one-quarter of patients with IBD. A majority of patients with these abnormalities were asymptomatic.


Diffusion abnormality Interstitial lung disease Lung function tests Pulmonary involvement 


Source of funding

This study was funded by the National Health and Education Society, Mumbai.


  1. 1.
    van Lierop PP, Samsom JN, Escher JC, et al. Role of the innate immune system in the pathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009;48:142–51.PubMedCrossRefGoogle Scholar
  2. 2.
    Higenbottam T, Cochrane GM, Clark TJ, et al. Bronchial disease in ulcerative colitis. Thorax. 1980;35:581–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Kraft SC, Earle RH, Roesler M, et al. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med. 1976;136:454–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest. 2007;131:524–32.PubMedCrossRefGoogle Scholar
  5. 5.
    Tzanakis NE, Tsiligianni IG, Siafakas NM. Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol. 2010;16:299–305.PubMedCrossRefGoogle Scholar
  6. 6.
    Mahadeva R, Walsh G, Flower CD, et al. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J. 2000;15:41–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol. 2006;12:4819–31.PubMedGoogle Scholar
  8. 8.
    Songur N, Songur Y, Tuzun M, et al. Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease. J Clin Gastroenterol. 2003;37:292–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Camus P, Piard F, Ashcroft T, et al. The lung in inflammatory bowel disease. Medicine (Baltimore). 1993;72:151–83.Google Scholar
  10. 10.
    Tzanakis N, Bouros D, Samiou M, et al. Lung function in patients with inflammatory bowel disease. Respir Med. 1998;92:516–22.PubMedCrossRefGoogle Scholar
  11. 11.
    Casey MB, Tazelaar HD, Myers JL, et al. Noninfectious lung pathology in patients with Crohn's disease. Am J Surg Pathol. 2003;27:213–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Parry SD, Barbatzas C, Peel ET, et al. Sulphasalazine and lung toxicity. Eur Respir J. 2002;19:756–64.PubMedCrossRefGoogle Scholar
  13. 13.
    Herrlinger KR, Noftz MK, Dalhoff K, et al. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol. 2002;97:377–81.PubMedCrossRefGoogle Scholar
  14. 14.
    Tunc B, Filik L, Bilgic F, et al. Pulmonary function tests, high-resolution computed tomography findings and inflammatory bowel disease. Acta Gastroenterol Belg. 2006;69:255–60.PubMedGoogle Scholar
  15. 15.
    Sarioglu N, Turkel N, Sakar A, et al. Lung involvement in inflammatory bowel diseases. Ann Saudi Med. 2006;26:407–8.PubMedGoogle Scholar
  16. 16.
    Sethy PK, Dutta U, Aggrawal AN, et al. Pulmonary and hematological alterations in idiopathic ulcerative colitis. Indian J Gastroenterol. 2003;22:176–9.PubMedGoogle Scholar
  17. 17.
    Yilmaz A, Yilmaz Demirci N, Hosgün D, et al. Pulmonary involvement in inflammatory bowel disease. World J Gastroenterol. 2010;16:4952–7.PubMedCrossRefGoogle Scholar

Copyright information

© Indian Society of Gastroenterology 2011

Authors and Affiliations

  • Devendra Desai
    • 1
    Email author
  • Samir Patil
    • 1
  • Zarir Udwadia
    • 2
  • Shailendra Maheshwari
    • 3
  • Philip Abraham
    • 1
  • Anand Joshi
    • 1
  1. 1.Division of GastroenterologyP D Hinduja National HospitalMumbaiIndia
  2. 2.Chest Medicine, P D Hinduja National HospitalMumbaiIndia
  3. 3.Department of RadiologyP D Hinduja National HospitalMumbaiIndia

Personalised recommendations